LEP and breast carcinoma: Significant migration of MCF7, MDA-MB-468, MDA-MB-231, SUM149, SUM159 and T47D breast cancer cells observed in the presence of leptin was inhibited in the presence of HNK treatment (Figure 1G, Supplementary Figure 1B, 1C).